Chemours schedules Q4/FY23 earnings release for March 27, conference call March 28

Chemours Co

Expects to issue Q4 and full-year 2023 financial results after market close on March 27, 2024.
Annual Report on Form 10-K for year ended December 31, 2023 also to be filed March 27.
Conference call to discuss results at 8:00 a.m. EDT on March 28, 2024; webcast on investors.chemours.com.
Interim CFO Matthew Abbott signed the filing; no financial results disclosed in this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.